How to Cite this Article: Fernández RM, Núñez-Torres R, García L, de Agustín JC, Antiñolo G, Borrego S. 2012. Association of X-linked hydrocephalus and Hirschsprung disease: Report of a new patient with a mutation in the L1CAM gene. Am J Med Genet Part A 158A:816–820.
Association of X-linked hydrocephalus and Hirschsprung disease: Report of a new patient with a mutation in the L1CAM gene†
Article first published online: 17 FEB 2012
Copyright © 2012 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part A
Volume 158A, Issue 4, pages 816–820, April 2012
How to Cite
Fernández, R. M., Núñez-Torres, R., García-Díaz, L., de Agustín, J. C., Antiñolo, G. and Borrego, S. (2012), Association of X-linked hydrocephalus and Hirschsprung disease: Report of a new patient with a mutation in the L1CAM gene. Am. J. Med. Genet., 158A: 816–820. doi: 10.1002/ajmg.a.35244
- Issue published online: 23 MAR 2012
- Article first published online: 17 FEB 2012
- Manuscript Accepted: 26 DEC 2011
- Manuscript Received: 7 SEP 2011
- Instituto de Salud Carlos III, Spain. Grant Number: PI101290
- Consejeria de Innovación Ciencia y Empresa de la Junta de Andalucia. Grant Number: CTS 2590
- Consejeria de Salud de la Junta de Andalucia. Grant Number: PI0249-2008
- Hirschsprung disease;
- RET proto-oncogene;
X-linked hydrocephalus (XLH) has an incidence of 1/30,000 male births and is characterized by intellectual disability, spastic paraplegia, adducted thumbs, and agenesis of corpus callosum, and/or corticospinal tract. The great proportion of cases is ascribed to loss of function mutations of L1CAM gene. Hirschsprung disease (HSCR) is characterized by the absence of ganglion cells in the submucosal and myenteric plexuses along a variable portion of the intestinal tract and has incidence of about 1/5,000. Although with several genes involved in its pathogenesis, the major HSCR gene is the RET proto-oncogene. To date only a few patients have been reported with both phenotypes and mutations in the L1CAM gene. In this report, we describe a new patient with concurrent XLH and HSCR. L1CAM mutational screening showed the presence of the G698R hemizygous mutation, which is a deleterious substitution affecting a key residue necessary for the correct folding of the protein. Moreover, the patient also carried the transcriptional enhancer RET mutation (c.73 + 9277T > C) in heterozygosis. We speculate that both the RET enhancer variant, and the L1CAM mutation may act in combination to produce the enteric phenotype, probably with the participation of other still unidentified molecular events. While it is obvious that additional studies are necessary to further delineate the association between XLH and HSCR in the presence of L1CAM mutations, the documentation of this new patient reinforces the role of this gene acting either in a direct or indirect way in the pathogenesis of Hirschsprung disease. © 2012 Wiley Periodicals, Inc.